| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.09. | Zhongchao Inc. - 6-K, Report of foreign issuer | 15 | SEC Filings | ||
| 11.08. | Zhongchao Inc. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| ZHONGCHAO Aktie jetzt für 0€ handeln | |||||
| 23.07. | Morning Market Movers: 707 Cayman, Zhongchao, NVE Corporation, Medpace See Big Swings | 1.513 | AFX News | BEIJING (dpa-AFX) - At 8:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 22.07. | Zhongchao Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 03.07. | Zhongchao Stock Surges 200% After Hours: Here's Why | 16 | Benzinga.com | ||
| 25.06. | Zhongchao announces 1-for-3 share consolidation | 1 | Seeking Alpha | ||
| 25.06. | Zhongchao kündigt Aktienzusammenlegung im Verhältnis 1:3 an | 22 | Investing.com Deutsch | ||
| 25.06. | Zhongchao announces 1-for-3 reverse stock split effective Sunday | 2 | Investing.com | ||
| 25.06. | Zhongchao Inc. Announces 1-for-3 Share Consolidation | 515 | PR Newswire | SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 23.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | Zhongchao führt am Sonntag Reverse-Aktiensplit im Verhältnis 1:31 durch | 3 | Investing.com Deutsch | ||
| 04.06. | Zhongchao Inc. Announces 1-for-31 Share Consolidation | 265 | PR Newswire | SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 29.05. | Zhongchao prices $5 million public offering at $0.54 per unit | 18 | Investing.com | ||
| 29.05. | Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering | 257 | PR Newswire | SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services... ► Artikel lesen | |
| 22.05. | Zhongchao Inc. - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 07.05. | Zhongchao Inc. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 03.04. | Zhongchao Inc. - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 26.02. | Zhongchao Inc. Announces 1-for-8 Share Consolidation | 241 | PR Newswire | SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,120 | -0,90 % | Eckert&Ziegler-Aktie im Check am 19.09. (10:40 Uhr): Meine aktuelle Lageeinschätzung | ||
| SERNOVA BIOTHERAPEUTICS | 0,068 | +5,26 % | Sernova Biotherapeutics Inc: Sernova shareholder Sangha to vote "yes" in takeover | ||
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| UNIDOC HEALTH | 0,049 | -8,89 % | UniDoc Health Corp.: UniDoc Health Equips San Juan, Puerto Rico Ambulances With Live Patient Video | Upgraded E-PTZ Camera Integrates into UniDoc Connect for Full In-Transit Patient Coverage Across San Juan's Ambulance Fleet TORONTO, ON / ACCESS Newswire / September 17, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,970 | +2,57 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUEST DIAGNOSTICS | 213,40 | -0,56 % | Humanity Health Inc.; Quest Diagnostics: Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com | Individuals in the U.S. can now add Humanity Biological Age's lab-informed insights to select health profile tests purchased through Quest's consumer-initiated testing platformLONDON, Aug.... ► Artikel lesen | |
| QUIDELORTHO | 9,076 | -1,99 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,395 | -0,62 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 7,030 | -1,82 % | Lifeward legt Termin für jährliche und außerordentliche Hauptversammlung 2026 fest | ||
| SENSEONICS | 7,850 | -5,99 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 0,965 | -0,35 % | Tempest Therapeutics: Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform | -Transaction complements Tempest's existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in... ► Artikel lesen |